At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
IMVTU Immunovant, Inc.
Halted 06-12 15:59:28 EDT
30.28
+0.00
0.00%
High30.28Low30.28Vol0.00
Open30.28D1 Closing30.28Amplitude0.00%
Mkt Cap1.91BTradable Cap346.61MTotal Shares63.01M
T/O0.00T/O Rate0.00%Tradable Shares11.45M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--
No data available

Introduction

Company Name.
Immunovant, Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It is developing IMVT-1401, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as has completed initiation of Phase II clinical trials for the treatment of warm autoimmune hemolytic anemia. The company is headquartered in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.
Issue price:
--
Invest in Global Markets with Tiger Brokers!
Open App